HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas J Hund Selected Research

Calcium-Calmodulin-Dependent Protein Kinase Type 2

1/2021Phospho-ablation of cardiac sodium channel Nav1.5 mitigates susceptibility to atrial fibrillation and improves glucose homeostasis under conditions of diet-induced obesity.
1/2020MICAL1 constrains cardiac stress responses and protects against disease by oxidizing CaMKII.
1/2020Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart.
12/2018βIV-Spectrin regulates STAT3 targeting to tune cardiac response to pressure overload.
11/2018Oxidative stress creates a unique, CaMKII-mediated substrate for atrial fibrillation in heart failure.
10/2018CaMKII-dependent late Na+ current increases electrical dispersion and arrhythmia in ischemia-reperfusion.
7/2015Role of CaMKII in cardiac arrhythmias.
7/2014Tubulin polymerization disrupts cardiac β-adrenergic regulation of late INa.
1/2014Modeling CaMKII in cardiac physiology: from molecule to tissue.
8/2013Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas J Hund Research Topics

Disease

31Cardiac Arrhythmias (Arrythmia)
04/2021 - 11/2008
16Heart Failure
01/2021 - 03/2010
10Heart Diseases (Heart Disease)
04/2021 - 09/2008
9Cardiovascular Diseases (Cardiovascular Disease)
10/2019 - 10/2008
8Fibrosis (Cirrhosis)
01/2021 - 04/2012
8Sick Sinus Syndrome
07/2014 - 10/2008
7Atrial Fibrillation
01/2021 - 09/2011
7Myocardial Infarction
03/2013 - 09/2008
5Hypertrophy
01/2022 - 12/2009
4Ischemia
10/2018 - 09/2007
4Ventricular Tachycardia
10/2018 - 01/2012
4Ankyrin-B-Related Cardiac Arrhythmia
05/2013 - 08/2009
4Infarction (Infarctions)
01/2013 - 09/2008
3Bradycardia
11/2014 - 11/2008
3Sudden Death
03/2013 - 11/2010
3Cardiac Sudden Death (Sudden Cardiac Arrest)
08/2012 - 08/2009
2Polymorphic catecholergic ventricular tachycardia
01/2020 - 06/2016
2Cardiomegaly (Heart Hypertrophy)
01/2019 - 12/2018
2Cardiomyopathies (Cardiomyopathy)
01/2019 - 03/2013
2Channelopathies
10/2015 - 01/2011
2Atrial Remodeling
05/2012 - 09/2008
1Asthma (Bronchial Asthma)
09/2021
1Body Weight (Weight, Body)
01/2021
1Obesity
01/2021
1Edema (Dropsy)
11/2020
1Seizures (Absence Seizure)
01/2020
1Chronic Disease (Chronic Diseases)
01/2020
1Congenital Structural Myopathies (Centronuclear Myopathy)
01/2017
1Muscular Diseases (Myopathy)
01/2017
1Deafness (Deaf Mutism)
01/2017
1Animal Disease Models
07/2015
1Multiple Sclerosis
05/2015
1Osteoporosis
03/2014
1Ataxia (Dyssynergia)
10/2013
1Coronary Occlusion
01/2013
1Hypertension (High Blood Pressure)
08/2011
1Myotonia
10/2010
1Epilepsy (Aura)
10/2010

Drug/Important Bio-Agent (IBA)

20Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2021 - 09/2008
19AnkyrinsIBA
04/2021 - 10/2008
13SpectrinIBA
01/2022 - 10/2013
13Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2009
12Ion Channels (Ion Channel)IBA
04/2021 - 09/2008
6SodiumIBA
01/2021 - 01/2011
5Calcium-Calmodulin-Dependent Protein KinasesIBA
01/2020 - 11/2008
5CalciumIBA
01/2020 - 09/2008
4Sodium Channels (Sodium Channel)IBA
01/2021 - 04/2012
3Adrenergic Agents (Adrenergic Drugs)IBA
06/2016 - 06/2014
3Connexin 43 (Connexin43)IBA
03/2013 - 09/2007
3Membrane Proteins (Integral Membrane Proteins)IBA
05/2012 - 07/2010
2Pharmaceutical PreparationsIBA
01/2021 - 07/2014
2Calmodulin (Calcium-Dependent Activator Protein)IBA
12/2018 - 12/2012
2Phosphotransferases (Kinase)IBA
12/2018 - 12/2012
2CatecholaminesIBA
06/2016 - 11/2015
2CalpainIBA
01/2016 - 08/2012
2Oxidants (Oxidizing Agents)IBA
03/2013 - 08/2011
2ConnexinsIBA
01/2013 - 09/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2012 - 05/2012
2Angiotensin IIIBA
05/2012 - 08/2011
2Adenosine Triphosphatases (ATPase)IBA
11/2010 - 09/2010
1VitaminsIBA
09/2021
1LipidsIBA
09/2021
1LDL CholesterolIBA
09/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Biological ProductsIBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020
1Adenosine (Adenocard)FDA LinkGeneric
01/2020
1N-methyladenosineIBA
01/2019
16-methyladenineIBA
01/2019
1tRNA MethyltransferasesIBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
11/2018
1Mexiletine (Mexitil)FDA LinkGeneric
10/2018
1Cytoskeletal ProteinsIBA
10/2015
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2015
1Voltage-Gated Sodium ChannelsIBA
08/2015
14-Aminopyridine (4 Aminopyridine)FDA Link
05/2015
1Paclitaxel (Taxol)FDA LinkGeneric
07/2014
1potassium channel protein TREK-1IBA
04/2014
1Potassium Channels (Potassium Channel)IBA
04/2014
1Ibandronic Acid (Boniva)FDA Link
03/2014
1Diphosphonates (Bisphosphonates)IBA
03/2014
1CaMKII inhibitor AIPIBA
08/2013
1RanolazineFDA Link
08/2013
1Protein Isoforms (Isoforms)IBA
03/2013
1AntioxidantsIBA
03/2013
1Streptozocin (Streptozotocin)FDA Link
03/2013
1MitoTEMPOIBA
03/2013
1gamma Catenin (Plakoglobin)IBA
03/2013
1GTP-Binding Proteins (G-Protein)IBA
01/2013
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2012
1Peptide Hydrolases (Proteases)FDA Link
08/2012
1CollagenIBA
04/2012
1Peptides (Polypeptides)IBA
01/2012
1Sodium-Calcium ExchangerIBA
11/2010
1Membrane Transport Proteins (Biological Pump)IBA
09/2010
1Adenosine Triphosphate (ATP)IBA
09/2010

Therapy/Procedure

5Therapeutics
01/2020 - 05/2015
1Artificial Pacemaker
08/2011